Journal of Oncology Pharmacy Practice · 2012 · 11 citations · 16 references
MedicineOncologyPharmacologyMetastasisNeoplasiaRenal PathologyCancer ImmunotherapyImmune-related Adverse EventsMalignant NeoplasmsMetastatic Disease TreatmentRenal NeoplasmsRenal ToxicityDermatologic Adverse EventsDrug-induced Acneiform EruptionMetastatic Kidney CancerNephrotic Syndrome TreatmentSecondary Glomerular Diseases
Proteinuria is common adverse effect that occurs after the use of bevacizumab, but it occurs rarely during administration of cetuximab. We report the first case of nephrotic syndrome induced by cetuximab after completing mFOLFOX6 with bevacizumab followed by sLV5FU2 with bevacizumab for metastatic rectal cancer. Prior to the administration of cetuximab, the patient had never presented proteinuria. After the completion of the loading (400 mg/m(2)) and two subsequent maintenance (250 mg/m(2)) infusions of cetuximab, edema of the lower extremities occurred concomitantly with facial acneiform rash. Based on the laboratory data, diagnosis of nephrotic syndrome was made and secondary diseases of nephrotic syndrome were excluded. Oral administration of prednisolone (0.6 mg/kg/day) was initiated, resulting in no response. The trigger of nephrotic syndrome other than cetuximab was not suggested and attention on occurrence of proteinuria must be devoted to this medicine.
16
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Cetuximab for the Treatment of Colorectal Cancer
Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text
Medicine, Oncology, Pharmacology +17
Cetuximab in the treatment of colorectal cancer.
Richard M. Goldberg, Alan P. Venook, Richard L. Schilsky · PubMed · 2004 · 1.5K citations
Medicine, Oncology, Pharmacology +10
VEGF Inhibition and Renal Thrombotic Microangiopathy
Vera Eremina, J. Ashley Jefferson, Jolanta Kowalewska et al. · New England Journal of Medicine · 2008 · 1.5K citations · Full text
Alberto Sobrero, Joan Maurel, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2008 · 952 citations · Full text
Medicine, Oncology, Pharmacology +14